ST
Savannah Therapeutics, Inc
SEC filingOther Health Care · Riverdale, MD
Amount raised$3.9Msold at filing
Total offering$6M$2.1M still open
Investors in the raise28count reported to the SEC
FiledSep 11, 2026first sale Apr 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Matthew DowlingDirector
Thomas WollanExecutive Officer
Executive officers, directors and promoters as listed on the Form D.